期刊文献+

泌尿外科进展

下载PDF
导出
摘要 2008年至2009年度是中国泌尿外科蓬勃发展并取得辉煌成就的一年。2008年底第26届世界腔内泌尿外科大会(WCE)成功在中国上海召开。2009年国际泌尿外科学会(SIU)第30届大会也选择在中国上海举行。同时,越来越多的中国泌尿外科医生开始积极参加AUA和EUA年会,
作者 张元芳 王翔
出处 《临床外科杂志》 2010年第1期27-29,共3页 Journal of Clinical Surgery
  • 相关文献

参考文献15

  • 1Yamamoto Y,Eguchi S,Junpei A,et al.Intercellular centrosome number is correlated with the copy number of chromosomes in bladder cancer[J].Cancer Genet Cytogenet,2009,191(1):38-42.
  • 2徐罡,项翠琴,陆晔,康晓楠,王文静,廖萍,丁强,张元芳.应用SELDI—TOF—MS技术联合CT鉴别肾脏良恶性占位[J].中华医学杂志,2008,88(12):858-860. 被引量:4
  • 3Xu G,Xiang CQ,Lu Y,et al.Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma[J].Cancer Letters,2009,282(2):205-213.
  • 4Xu G,Xiang CQ,Lu Y,et al.SELDI-TOF-MS-based serum proteomic screening in combination with CT scan distinguishes renal cell carcinoma from benign renal tumors and healthy persons[J].Technol Cancer Res Treat,2009,8(3):225-230.
  • 5Sonpavde G,Huston TE,Rini BI.Axitinib for renal cell carcinoma[J].Expert Opin Investig Drugs,2008,17(5):741-748.
  • 6Sonpavde G,Hutson TE,Sternberg CN.Pazapanib,a potent orally administered small molecule multi-targeted tyrosine kinase inhibitor for renal cell carcinoma[J].Expert Opin Investig Drugs,2008,17(2):253-261.
  • 7Schrader AJ,Olbert PJ,Hegele A,et al.Metastatic non-clear cell renal cell carcinoma:current therapeutic options[J].BJU Int,2008,10(11):1343-1345.
  • 8Sreekumar A,Poisson LM,Rajendiran TM,et al.Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression[J].Nature,2009,457(7231):910-914.
  • 9Gettman MT,Box G,Averch T,et al.Consensus statement on natural orifice transluminal endoscopic surgery and single-incision laparoscopic surgery:heralding a new era in urology[J] ? Eur Urol,2008,53(6):1117-1120.
  • 10Raman JD,Cadeddu JA,Rao P,et al.Single-incision laparoscopic surgery:initial urological experience and comparison with natural-orifice transluminal endoscopic surgery[J].BJU Int,2008,101(12):1493-1496.

二级参考文献8

  • 1吴登龙,王文静,关明,金三宝,金重睿,张元芳.表面增强激光解吸/离子化质谱蛋白质芯片技术在筛选肾癌患者尿液标记物中的应用[J].中华医学杂志,2004,84(13):1092-1095. 被引量:22
  • 2Byvatov E, Schneider G. SVM-based feature selection for characterization of focused compound collections. J Chem Inf Comput Sci ,2004, 44:993-999.
  • 3Tolson J, Bogumil R, Brunst E, et al. Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients. Lab Invest, 2004, 84: 845 -856.
  • 4Hara T, Honda K, Ono M, et al. Identification of 2 serum biomarkers of renal cell carcinoma by surface enhanced laser desorption/ionization mass spectrometry. J Urol, 2005, 174 (4Pt1) :1213-1217.
  • 5Diamandis EP. Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis : next steps. Cancer Res,2006, 66:5540-5541
  • 6Engwegen JY, Gast MC, Schellens JH, et al. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol Sci,2006, 27: 251-259.
  • 7Silverman SG, Mortele KJ, Tuncali K, et al. Hyperattenuating renal masses: etiologies, pathogenesis, and imaging evaluation. Radiographies,2007, 27 : 1131-1143.
  • 8Remzi M, Katzenbeisser D, Waldert M, et al. Renal tumour size measured radiologically before surgery is an unreliable variable for predicting histopathological features: benign tumours axe not necessarily small. BJU Int, 2007, 99:1002-1006.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部